Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Scott Schoenhaus

KeyBanc Capital Markets · covers Healthcare

Period: Reporting period mapped to calendar 2026 Q3.

Limited coverage. Only 1 question of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
1on tracked calls
Challenge rate
0%none of 1 questionLimited sample
Companies
1questioned at least once
Reporting periods
1with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 1 of 1 question from 1 company

VEEVVeeva Systems Inc.1 question · 1 reporting period · 0 of 1 challenging
VEEV company page →

Calendar 2026 Q3

are you seeing pharma marketing advertising budgets become better than they were 90 days ago?

DemandMacroeconomicTranscript · FY2027 Q2 →
Show response

Paul Shawah said pharma digital marketing budgets remain strong and that AI is a long-term tailwind as Crossix measures and optimizes AI-driven doctor engagement.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
VEEV Veeva Systems Inc.1—Rate withheld: fewer than 3 questions
  • VEEV
    Veeva Systems Inc. · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2026 Q310%none of 1 question1
  1. 2026 Q31 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Demand1
  • Macroeconomic1